D-0513-2026 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-0513-2026 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 6, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential leaks from perforations in bags. The recall status is ongoing. Affected quantity: 43,225 bags.

Recall details

Product Type
Drugs
Report Date
May 13, 2026
Initiation Date
Apr 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43,225 bags

Product description

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. LM/LC, 2L 5PK, Part Number 054-20222, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.

Reason for recall

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Distribution pattern

Nationwide in the USA

Code information

Lots 25CU02002, 25CU02011, 25CU02012, 25CU02013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0513-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0513-2026. Report a data issue: hello@regdatalab.com.